Antiplatelet therapy and prevention of ischaemic events: CAPRIE

Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.

Morrell J. Initiating antiplatelet therapy in diabetes: a PCO view. Br J Diabetes Vasc Dis 2003;3:249-53.

CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.

Ringleb PA , Bhatt DL , Hirsch AT , Topol EJ , Hacke W. ; Caprie Investigators. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischaemic events. Stroke 2004;35:528-32.

Bhatt DL , Chew DP , Hirsch AT , Ringleb PA , Hacke W. , Topol EJ Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery . Circulation 2001 ;103 :363-8.

Bhatt DL , Marso SP , Hirsch AT , Ringleb P. , Hacke W. , Topol EJ Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002;90:625-8.

Bhatt DL , Foody JM , Hirsch AT , Ringleb P. , Hacke W. , Topol EJ Complementary, additive benefit of clopidogrel and lipid-lowering therapy in patients with atherosclerosis. J Am Coll Cardiol 2000;35(sup B pl A):326.

Bhatt DL , Marso SP , Hirsch AT , Ringleb PA , Hacke W. , Topol EJ Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002;90:625-8.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-97.

Williams B. , Poulter NR , Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004;18:139-85.

National Institute for Health and Clinical Excellence. Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. Technology Appraisal 90. http://www.nice.org.uk/page.aspx?o=259254 (last accessed 23 June 2005).

Gaspov JM , Coxson PG , Goldman PA et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2002;346:1800-05.

Schleinitz MD , Heidenreich PA A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone. Ann Intern Med 2005;142:251-9.

Diener HC , Cunha L. , Forbes C. , Sivenius J. , Smets P. , Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.

Tran H. , Anand SS Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease and peripheral arterial disease. JAMA 2004 ;292: 1867-74.

The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes with ST-segment elevation. N Engl J Med 2001;345:494-502.

Diener HC , Bogousslavsky J. , Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH). Lancet 2004;364:331-7.

For and Against. Aspirin for everyone older than 50? BMJ 2005;330: 1400-43.

Hung J. Aspirin for cardiovascular disease prevention. MJA 2003;179: 147-52.

Sanofi Pharma Bristol-Myers Squibb SNC. Plavix® (clopidogrel): summary of product characteristics, 2003.

Proton pump inhibitors for acute upper GI bleeding. Drug & Therapeutics Bulletin 2004;42:41-2.